Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study
Laura E. Targownik, Eric I. Benchimol, Charles N. Bernstein, Harminder Singh, Lisa Lix, A. Tennakoon, Stella Leung, Antonio Aviña, Stephanie Coward, Jennifer Jones, Gil Kaplan, Sanjay K. Murthy, Geoffrey C. Nguyen, Juan Nicolás Peña-Sánchez
Dive into the research topics of 'Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study'. Together they form a unique fingerprint.